MEETINGS - Workshop on Central-East European Countries and European Community: IVD (in vitro diagnostic) Directive 98/79/EC and Central-East European Countries Regulations (Czech Republic) September 2002:
This article was originally published in Clinica
The European Diagnostics Manufacturers Association (EDMA) is hosting a workshop on Central-East European Countries and European Community: IVD Directive 98/79/EC and Central-East European Countries Regulations on September 24 2002 at the Hotel Pyramida, Prague, Czech Republic. Workshop highlights include the EDMA Central Europe Working Party and its activities, details on Switzerland adopting the CE mark, industry and competent authority perspectives of the IVD Directive, and CEEC regulations and future prospects. Further details from EDMA, on tel: +32 2772 2225; fax: +32 2772 2329; email: email@example.com www.edma.ivd.be
You may also be interested in...
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.
With the pre-GDUFA backlog largely acted upon, the FDA expects ANDA approvals to decrease, but supplement actions to increase in FY 2020 and FY 2021.